Heron Therapeutics Inc. (NASDAQ: HRTX) Announce Commercial Availability of ZYNRELEF For Post-Operative Pain Management

Heron Therapeutics Inc. (NASDAQ: HRTX) has announced the commercial availability of ZYNRELEF, an extended-release solution, at all major national wholesalers and specialty distributors across the US.  FDA approved ZYNRELEF in May  ZYNRELEF received FDA approval on May 12, 2021, for use in individuals with pariarticular installation or soft tissue to […]